SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies

Abstract

A recent paper published in Science describes the detection of IgG antibody responses in individuals infected by severe acute respiratory syndrome coronavirus (SARS-CoV-2). The authors also examined the duration of antibody production and the correlation between IgG antibody titers and neutralizing antibody titers. 1 This study provides information about the kinetics of antibody production, and the functionality and longevity of these antibodies, in patients with Coronavirus Disease 2019 (COVID-19).

Cited by papers we hold 5

• SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment · 2022
  Not checked
• SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines · 2022
  No notice
• Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy · 2021
  No notice
• Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice · 2021
  No notice
• Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.